alexa Carcinoma of the vulva: analysis of treatment and survival.


Journal of Cancer Clinical Trials

Author(s): Podratz KC, Symmonds RE, Taylor WF, Williams TJ, Podratz KC, Symmonds RE, Taylor WF, Williams TJ

Abstract Share this page

Abstract The treatment of 224 patients with invasive squamous cell carcinoma of the vulva over a 20-year interval at the Mayo Clinic resulted in an overall survival rate of 75\%, compared with 89\% for age-matched controls. For patients with stage I disease, 5-year survival was 90\%; for those with stages II, III, and IV, it was 81, 68, and 20\%, respectively. A precipitous decline in survival rates was noted when metastases to regional nodes were encountered, when lesion size was more than 3 cm, and when histologic dedifferentiation exceeded grade 2. Incorrect clinical staging efforts were observed in 25\% of the cases, so the necessity for surgical staging was apparent.
This article was published in Obstet Gynecol and referenced in Journal of Cancer Clinical Trials

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version